OpenLegislation

Chapter II Minimum requirements for the quality systems for the performance of pharmacovigilance activitiesF1

United Kingdom

Original text. Later amendments are not shown.

  1. 1General provisions
  2. 2Minimum requirements for the quality systems for the performance of pharmacovigilance activities by marketing authorisation holders
  3. 3Minimum requirements for the quality systems for the performance of pharmacovigilance activities by national competent authorities and the Agency

Annotations

Textual amendments

F1

Regulation revoked in part (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(t) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)